N-acetylcysteine reduces disease activity by blocking mTOR in T cells of lupus patients

Arthritis & Rheumatism, 05/11/2012

This pilot study suggests that N–acetylcysteine (NAC) safely improves lupus disease activity by blocking mTOR in T lymphocytes.

Print Article Summary Cat 2 CME Report